ArticlePloS one2025
Gender and medication use in Turkey: Evidence from a general population survey.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gender differences in health behaviors and outcomes were commonly documented by researchers. The focus of this study was the analysis of gender differences in medication use for a general population in Turkey. It also explored a range of factors associated with medication use at the individual level. A nationally representative cross-sectional data set was obtained from the 2019 wave of the Turkish Health Survey. The sample of this study included 17,083 adults residing in different regions of Turkey. Conditional mixed-process regression models were estimated for the whole sample and subsamples by gender. The rates of prescribed and non-prescribed medication use were 40.7% and 30.2%, respectively, in the adult population of Turkey. There were significant gender differences in medication use in the Turkish case. Females were 19.4% more likely to use prescribed medication, and they were 30.8% more likely to use non-prescribed medication compared to males in Turkey. There were negative associations between prescribed and non-prescribed medication use. On average, females were 9.2% less likely to report higher levels of health status, and they were 18.4% more likely to use healthcare services. Individuals with higher levels of self-rated health status were less likely to use prescribed medication. Both prescribed and non-prescribed medication use were positively related to healthcare service use. Complementing the earlier literature, the results of the present study demonstrated that gender-specific designs should be considered by health policies on the use of medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.